Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2745 (LINC02745) is a human gene that produces a long intergenic non-coding RNA transcript. These RNAs are defined as autonomously transcribed and not overlapping protein-coding genes. Most lincRNAs function primarily by modulating gene expression, affecting chromatin state, or influencing transcriptional programs, and often have tissue-specific roles. For LINC02745, specific functional studies or disease associations have not been described, reflecting the current limited understanding of most annotated lincRNAs. It is not classified as a conventional drug target, does not have established interacting drugs, and is not used as a biomarker in clinical practice.
Not applicable. There are no approved or investigational drugs known to target this molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2745 (LINC02745).